Insider trades appear within seconds, the rest within the hour.

Get alerts

← Feed

AKBANasdaq

Akebia Therapeutics, Inc.

Alert me on AKBA
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

After each filing

8
Jul 2 Sale Ostrowski Erik Insider
1 week
+12.9%S&P +1.4%
1 month
+5.6%S&P +1.7%
3 months
−29.8%S&P +2.8%
6 months
Result in36 trading days
Mar 6 Buy Butler John P. Insider
1 week
+15.0%S&P −1.5%
1 month
+8.7%S&P −1.7%
3 months
−26.4%S&P +10.0%
6 months
−23.3%S&P +15.2%
Feb 5 Sale Malabre Richard C Insider
1 week
−1.4%S&P +0.5%
1 month
−2.2%S&P +0.1%
3 months
−14.5%S&P +8.3%
6 months
−34.1%S&P +14.7%
Feb 5 Sale Ostrowski Erik Insider
1 week
−1.4%S&P +0.5%
1 month
−2.2%S&P +0.1%
3 months
−14.5%S&P +8.3%
6 months
−34.1%S&P +14.7%
Feb 5 Sale Rucci Carolyn M. Insider
1 week
−1.4%S&P +0.5%
1 month
−2.2%S&P +0.1%
3 months
−14.5%S&P +8.3%
6 months
−34.1%S&P +14.7%
Show all 8
Feb 5 Sale Butler John P. Insider
1 week
−1.4%S&P +0.5%
1 month
−2.2%S&P +0.1%
3 months
−14.5%S&P +8.3%
6 months
−34.1%S&P +14.7%
Feb 5 Sale Burke Steven Keith Insider
1 week
−1.4%S&P +0.5%
1 month
−2.2%S&P +0.1%
3 months
−14.5%S&P +8.3%
6 months
−34.1%S&P +14.7%
Feb 5 Sale Grund Nicholas Insider
1 week
−1.4%S&P +0.5%
1 month
−2.2%S&P +0.1%
3 months
−14.5%S&P +8.3%
6 months
−34.1%S&P +14.7%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for AKBA

32 held · newest 532 held · newest 2
Loading the filings.
See all 32 filings for AKBA

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
$260KQ4 2025
$480KQ1 2026
$360KQ2 2026
$260KQ3 2026
Down 28 percent from Q2 2026. Reported by the company to the Senate each quarter.Original report ↗

Read from LDA.gov between Sep 23, 2026 and Nov 4, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.